Phase 1 trial of RLS-1496 demonstrates safety with no severe adverse events and significant reduction in inflammatory markers, highlighting its potential as a senolytic therapy for skin conditions lik...
Emerging studies show that aligning meals with circadian rhythms can reduce aging markers in organs like the heart and liver, offering practical strategies for longevity. Recent findings highlight how...
Recent NHANES analyses show that aligning meals with circadian rhythms, especially eating last meals early, reduces epigenetic age acceleration, with benefits varying by age and sex. New research from...
The FDA’s updated guidelines on cellular reprogramming, highlighted by Life Biosciences’ ER-100 trial for eye conditions, signal a pivotal shift that could accelerate anti-aging therapies,...
Recent research reveals APOE4 increases hippocampal neuron excitability before Alzheimer’s symptoms, offering early detection via interictal spikes and potential interventions targeting Nell2 pr...
uPAR-targeted CAR T cell therapy shows promising results in solid tumors, with recent clinical trials and FDA designations advancing cancer immunotherapy towards precision medicine. Recent advancement...
Muscle-generated exerkines in extracellular vesicles are crucial for exercise-induced health, with new research suggesting therapies for sarcopenia and metabolic diseases through inter-organ communica...
Analyzing recent rapamycin clinical trials for anti-aging, focusing on optimal dosing, safety, and the shift from off-label use to evidence-based protocols in longevity research. New human trials on r...
Recent studies show aging clocks integrating clinical and microbiome data can predict biological age, enabling personalized anti-aging interventions through tailored diets and therapies. Advancements ...
Recent studies highlight how probiotics and fecal microbiota transplantation reduce neuroinflammation and improve cognitive function in neurodegenerative diseases, offering new treatment avenues. New ...
